NOVATO, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), today announced that the first patient has been dosed in the pivotal Phase 3 Aspire study ( NCT06617429 ...

Exchange-traded funds (ETFs) can be a cost-effective method to invest in your future. Find the best brokers for ETFs that ...

Suite of software tools will empower ag lenders to streamline operations, find new customers faster, and build stronger relationshipsJOHNSTON, Iowa, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Growers Edge, a ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive Phase 2 results for two novel monoclonal antibodies targeting distinct domains of Factor XI. REGN7508 (catalytic domain) is ...

Security leaders offer advice on researching, piloting, and implementing the most frequently cited cyber tech pilots, ...

Irving Health Insurance Agent highlights the critical period at the end of each year as an optimal time for individuals and ...

The report highlights the key privacy and civil rights concerns that are directly related to the rapid development and ...

Today's widely anticipated Fed rate announcement will impact how much you can earn on savings accounts and CDs. Here's what ...

For the third time in five years, the Office of the Comptroller of the Currency issued an enforcement action against the ...

Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...

Health knowledge about sugar-sweetened beverages (SSBs) does not significantly reduce high SSB consumption, which is driven ...

A new National Academies report reviews scientific evidence on the relationship between moderate alcohol consumption and ...